Groowe Groowe / Newsroom / VRTX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

VRTX News

Vertex Pharmaceuticals Inc

Vertex to Participate in the Citi’s 2025 Global Healthcare Conference on December 3

businesswire.com
VRTX

COVID-19 Diagnostic Research Report 2025: 5 Year Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides - ResearchAndMarkets.com

businesswire.com
ABT AMGN BDX BIO CERN DGX DHR ENZ EXAS GILD HHC HOLX ILMN ISRG JNJ LH LMT MRNA MYL NBIX NOC NTRA NVTA ONVO ORCL PDD PFE QGEN QRVO REGN RHHBY RMD ROST SGEN SIGA SNPS SPLK SRPT STEM SYK TCOM TGT TMO TSLA TXG VRTX WBA XRAY

Immunoassay Market Research, Strategies, Trends and Forecasts Report 2025 with Executive Guides and Impact of Artificial Intelligence - ResearchAndMarkets.com

businesswire.com
ALGN AMZN BDX BIO BMY CDNS CERN CHKP CLVS CODX CRSP CYTK DELL DGX DHR DIS DTC DXCM ENZ EXAS FSLR GILD GOOG IDXX ILMN INCY INTC ISRG JNJ LULU LUMX MDLZ MRNA MSFT MYL NBIX NCLH NFLX NVS NVTA ORCL ORGO OSIP OTIS PANW PFE PG PGR PPC PRGO QCOM QGEN QORV QUID REGN ROCH ROST SGEN SIRI SNPS SPLK SRPT SWKS SYK TCOM TEAM TEVA TGT TMO TSLA TXN ULTA UNH VRTX WBA WDC WEC WFC XRAY XTRA ZBRA

ToolGen Completes U.S. Patent Registration for Core CRISPR Cas9 RNP Technology; Files U.S. Lawsuit Related to CASGEVY®

prnewswire.com
VRTX

Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week

businesswire.com
VRTX

Vertex Reports Third Quarter 2025 Financial Results

businesswire.com
VRTX

Vertex to Participate in the UBS Global Healthcare Conference on November 11

businesswire.com
VRTX

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

businesswire.com
VRTX

Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis

businesswire.com
VRTX